Biblio

Export 1398 results:
Author Title [ Type(Asc)] Year
Filters: First Letter Of Last Name is P  [Clear All Filters]
Journal Article
E. Drummond, Goñi, F., Liu, S., Prelli, F., Scholtzova, H., and Wisniewski, T., Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. s1, pp. S299-S312, 2018.
B. Seok Ye, Lee, Y., Kwak, K., Park, Y. - H., Ham, J. Hyun, Lee, J. Jung, Shin, N. - Y., Lee, J. - M., Sohn, Y. H., and Lee, P. Hyu, Posterior Ventricular Enlargement to Differentiate Dementia with Lewy Bodies from Alzheimer's Disease., J Alzheimers Dis, vol. 52, no. 4, pp. 1237-43, 2016.
C. Lomiguen, Vidal, L., Kozlowski, P., Prancan, A., and Stern, R., Possible Role of Chitin-Like Proteins in the Etiology of Alzheimer's Disease., J Alzheimers Dis, vol. 66, no. 2, pp. 439-444, 2018.
P. L. Nara, Sindelar, D., Penn, M. S., Potempa, J., and W Griffin, S. T., Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. 4, pp. 1417-1450, 2021.
P. L. Nara, Sindelar, D., Penn, M. S., Potempa, J., and W Griffin, S. T., Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease., J Alzheimers Dis, vol. 82, no. 4, pp. 1417-1450, 2021.
I. Luccarini, Pantano, D., Nardiello, P., Cavone, L., Lapucci, A., Miceli, C., Nediani, C., Berti, A., Stefani, M., and Casamenti, F., The Polyphenol Oleuropein Aglycone Modulates the PARP1-SIRT1 Interplay: An In Vitro and In Vivo Study., J Alzheimers Dis, vol. 54, no. 2, pp. 737-50, 2016.
A. Le Page, Lamoureux, J., Bourgade, K., Frost, E. H., Pawelec, G., Witkowski, J. M., Larbi, A., Dupuis, G., and Fülöp, T., Polymorphonuclear Neutrophil Functions are Differentially Altered in Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease Patients., J Alzheimers Dis, vol. 60, no. 1, pp. 23-42, 2017.
V. K. Ramanan, Heckman, M. G., Przybelski, S. A., Lesnick, T. G., Lowe, V. J., Graff-Radford, J., Mielke, M., Jack, C. R., Knopman, D. S., Petersen, R. C., Ross, O. A., and Vemuri, P., Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden., J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
V. K. Ramanan, Heckman, M. G., Przybelski, S. A., Lesnick, T. G., Lowe, V. J., Graff-Radford, J., Mielke, M., Jack, C. R., Knopman, D. S., Petersen, R. C., Ross, O. A., and Vemuri, P., Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden., J Alzheimers Dis, vol. 88, no. 4, pp. 1615-1625, 2022.
Sden Hoedt, Janssen, C. I. F., Astarita, G., Piomelli, D., Leijten, F. P. J., Crivelli, S. M., Verhoeven, A. J. M., De Vries, H. E., Walter, J., Martinez-Martinez, P., Sijbrands, E. J. G., Kiliaan, A. J., and Mulder, M. T., Pleiotropic Effect of Human ApoE4 on Cerebral Ceramide and Saturated Fatty Acid Levels., J Alzheimers Dis, vol. 60, no. 3, pp. 769-781, 2017.
C. S. Atwood and Perry, G., Playing Russian Roulette with Alzheimer's Disease Patients: Do the Cognitive Benefits of Lecanemab Outweigh the Risk of Edema, Stroke and Encephalitis?, J Alzheimers Dis, vol. 92, no. 3, pp. 799-801, 2023.
B. McGuinness, Fuchs, M., Barrett, S. L., A Passmore, P., and Johnston, J. A., Platelet Membrane β-Secretase Activity in Mild Cognitive Impairment and Conversion to Dementia: a Longitudinal Study., J Alzheimers Dis, vol. 49, no. 4, pp. 1095-103, 2016.
M. E. Petersen, Rafii, M. S., Zhang, F., Hall, J., Julovich, D., Ances, B. M., Schupf, N., Krinsky-McHale, S. J., Mapstone, M., Silverman, W., Lott, I., Klunk, W., Head, E., Christian, B., Foroud, T., Lai, F., H Rosas, D., Zaman, S., Wang, M. - C., Tycko, B., Lee, J., Handen, B., Hartley, S., Fortea, J., and O'Bryant, S., Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome., J Alzheimers Dis, vol. 79, no. 2, pp. 671-681, 2021.
L. Dayon, Wojcik, J., Galindo, A. Núñez, Corthésy, J., Cominetti, O., Oikonomidi, A., Henry, H., Migliavacca, E., Bowman, G. L., and Popp, J., Plasma Proteomic Profiles of Cerebrospinal Fluid-Defined Alzheimer's Disease Pathology in Older Adults., J Alzheimers Dis, vol. 60, no. 4, pp. 1641-1652, 2017.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., Plasma phospholipids identify antecedent memory impairment in older adults., Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., Plasma phospholipids identify antecedent memory impairment in older adults., Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
A. Pilotto, Imarisio, A., Carrarini, C., Russo, M., Masciocchi, S., Gipponi, S., Cottini, E., Aarsland, D., Zetterberg, H., Ashton, N. J., Hye, A., Bonanni, L., and Padovani, A., Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies., J Alzheimers Dis, vol. 82, no. 3, pp. 913-919, 2021.
A. Pilotto, Imarisio, A., Carrarini, C., Russo, M., Masciocchi, S., Gipponi, S., Cottini, E., Aarsland, D., Zetterberg, H., Ashton, N. J., Hye, A., Bonanni, L., and Padovani, A., Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies., J Alzheimers Dis, vol. 82, no. 3, pp. 913-919, 2021.
J. R. Wright, Deen, Q. Fahm E., Stevenson, A., Telford-Cooke, L., Parker, C., Martin-Ruiz, C., Steinert, J. R., Kalaria, R. N., and Mukaetova-Ladinska, E. B., Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease., J Alzheimers Dis, vol. 89, no. 4, pp. 1483-1492, 2022.
S. Pedrini, Hone, E., Gupta, V. B., James, I., Teimouri, E., Bush, A. I., Rowe, C. C., Villemagne, V. L., Ames, D., Masters, C. L., Rainey-Smith, S., Verdile, G., Sohrabi, H. R., Raida, M. R., Wenk, M. R., Taddei, K., Chatterjee, P., Martins, I., Laws, S. M., and Martins, R. N., Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance., J Alzheimers Dis, vol. 77, no. 2, pp. 733-744, 2020.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
K. E. Peters, Davis, W. A., Taddei, K., Martins, R. N., Masters, C. L., Davis, T. M. E., and Bruce, D. G., Plasma Amyloid-β Peptides in Type 2 Diabetes: A Matched Case-Control Study., J Alzheimers Dis, vol. 56, no. 3, pp. 1127-1133, 2017.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics., J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
N. Marchesi, Amadio, M., Colombrita, C., Govoni, S., Ratti, A., and Pascale, A., PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells., J Alzheimers Dis, vol. 54, no. 2, pp. 535-47, 2016.
W. A. Krudop, Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria., J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.

Pages